Market revenue in 2023 | USD 2.5 million |
Market revenue in 2030 | USD 8.7 million |
Growth rate | 19.3% (CAGR from 2023 to 2030) |
Largest segment | Cell & gene therapy |
Fastest growing segment | Cell & Gene Therapy |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cell & Gene Therapy, Immunotherapy |
Key market players worldwide | Charles River Laboratories International Inc, Boehringer Ingelheim, Thermo Fisher Scientific Inc, Lonza Group Ltd, Viva Biotech, VGXI, PlasmidFactory, BioCina, TriLink BioTechnologies, Esco Aster |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasmid dna contract manufacturing market will help companies and investors design strategic landscapes.
Cell & gene therapy was the largest segment with a revenue share of 60% in 2023. Horizon Databook has segmented the South Africa plasmid dna contract manufacturing market based on cell & gene therapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.
Factors driving the market are the growing popularity of gene therapy and rising burden of cancer cases. For instance, according to data gathered from the Global Cancer Observatory database of the International Agency for Research on Cancer, in 2020, there were 711,429 cancer deaths and 1.1 million new cancer cases in Africa.
The major cancer subtypes in Africa, according to the researchers, were liver, breast, cervical, prostate, and colorectal. Egypt, Nigeria, and South Africa were among the nations with the highest mortality rate related to cancer in this period.
Recent advancements in sequencing technology along with developments in related domains, such as molecular biology, virology, cancer, & synthetic chemistry, have made it easier to advance gene therapies.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa plasmid dna contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into South Africa plasmid dna contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account